Posted inBiotechnology
Brain circuits could explain cognitive symptoms in progressive supranuclear palsy
Progressive supranuclear palsy (PSP) is defined by the build-up of tau, yet patients often show cognitive and behavioral problems that…
Posted inBiotechnology
ASB2 reduces liver fat accumulation, boosting ILC1 balance and anti-tumor immunity
Viral Science News — A new study reports that an immune-regulating factor called ASB2 can reshape liver metabolism in a…
Posted inBiotechnology
Extracellular Matrix Stiffness Guides Region-Specific Lung Epithelial Differentiation in Organoids
Viral Science News — A new study from researchers including Z. Liao and H. Meng reports that mechanical cues from…
Posted inBiotechnology
Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador
Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease biotech Kira Pharmaceuticals.
Posted inBiotechnology
Repetitive Neuronal Stimulation Reprograms Mature Neurons Into Immature States
Decades after electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) became clinical workhorses for depression and schizophrenia, the cellular…
Posted inBiotechnology
5 emerging biotech hubs
Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging…
Posted inBiotechnology
Subjective Well-Being Mediates Link Between Caregiver Ability and Postoperative Resilience
A new study in BMC Geriatrics spotlights how the emotional lives of older adults may help determine psychological recovery after…
Posted inMedical Technology
Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecast
Abbott turned in a stronger than expected second quarter, allaying market concerns that subsidy cuts to the Affordable Care Act…
Posted inBiotechnology
Osaka University, DNAFORM and INRB develop portable rapid Ebola diagnostic system
In May 2026, the World Health Organization declared an international public health emergency over an outbreak of Ebola virus disease…
Posted inBiotechnology
GSK axes key cough drug candidate after phase 3 data end blockbuster hopes
GSK has ended development of camlipixant in chronic cough after delivering mixed phase 3 data, dealing a major blow to…